BIAFVSMXCT• 28 Days (Normalized)
BIAF vs MXCT (bioAffinity Technologies Inc. vs MaxCyte Inc.)
Showing Closing Date Range from Aug, 14 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BIAF Performance $7.95
+31.84%
bioAffinity Technologies Inc.
Normalized Baseline0.00%
MXCT Performance $1.16
-12.12%
MaxCyte Inc.
Normalized Baseline0.00%
Alpha Spread Margin BIAF LEADS
+43.96%
BIAF outperforming by 43.96%
BIAFMXCT
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BIAF MXCT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | BIAF Price | BIAF Gain (%) | MXCT Price | MXCT Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $7.95 | +31.84% | $1.16 | -12.12% | +43.96% |
| Sep 10, 2026 | $9.39 | +55.72% | $1.19 | -9.85% | +65.57% |
| Sep 09, 2026 | $10.50 | +74.13% | $1.22 | -7.58% | +81.71% |
| Sep 08, 2026 | $8.93 | +48.09% | $1.28 | -3.41% | +51.50% |
| Sep 04, 2026 | $15.27 | +153.23% | $1.28 | -3.03% | +156.26% |
| Sep 03, 2026 | $12.78 | +111.94% | $1.26 | -4.55% | +116.49% |
| Sep 02, 2026 | $9.75 | +61.69% | $1.27 | -3.79% | +65.48% |
| Sep 01, 2026 | $6.59 | +9.29% | $1.24 | -6.06% | +15.35% |
| Aug 31, 2026 | $4.56 | -24.38% | $1.29 | -2.27% | -22.11% |
| Aug 28, 2026 | $4.87 | -19.24% | $1.22 | -7.58% | -11.66% |
| Aug 27, 2026 | $5.06 | -16.09% | $1.28 | -3.03% | -13.06% |
| Aug 26, 2026 | $5.09 | -15.59% | $1.31 | -0.76% | -14.83% |
| Aug 25, 2026 | $5.19 | -13.93% | $1.35 | +2.27% | -16.20% |
| Aug 24, 2026 | $5.82 | -3.48% | $1.39 | +5.30% | -8.78% |
| Aug 21, 2026 | $6.00 | -0.50% | $1.38 | +4.55% | -5.05% |
Page 1 of 2